# Analysis of the Impact of Helicobacter Pylori on Salivary Microbiome in Adults

> **NCT03730766** · PHASE4 · UNKNOWN · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 60 (estimated)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Esomeprazole
- **DRUG:** Amoxicillin
- **DRUG:** Bismuth Potassium Citrate

## Key facts

- **NCT ID:** NCT03730766
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-01
- **Primary completion:** 2018-11-15
- **Final completion:** 2018-11-20
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2018-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03730766

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03730766, "Analysis of the Impact of Helicobacter Pylori on Salivary Microbiome in Adults". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT03730766. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
